Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma

D.L. Lildballe (1) , K.Q.T. Nguyen (2) , S.S. Poulsen (3) , H.O. Nielsen (4) , E. Nexo (1)

1 Department of Clinical Biochemistry; AarhusUniversity Hospital; Norrebrogade 44
2 Department of Clinical Biochemistry and Pharmacology; OdenseUniversity Hospital; Sdr. Boulevard 29
3 Institute of Biomedical Sciences; Panum Institute; University of Copenhagen Blegdamsvej 3
4 Department of Surgical Gastroenterology

No valid markers are routinely available to follow disease progression in patients with fibrolamellar hepatocellular carcinoma (FLHCC). We report data suggesting that the vitamin B12 binding protein haptocorrin (HC) may prove a suitable marker.

Mots clés: Fibrolamellar hepatocellular carcinoma; Vitamin B12; haptocorrin

D.L. Lildballe, K.Q.T. Nguyen, S.S. Poulsen, H.O. Nielsen, E. Nexo. Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma. EJSO - European Journal of Surgical Oncology, 2010, 37 (1), pp.72. ⟨10.1016/j.ejso.2010.11.001⟩. ⟨hal-00651627⟩